ShiraTronics Completes Australian Pilot Study Enrollment; Prepares for Pivotal Clinical Study

ShiraTronics, Inc., a pioneering clinical-stage medical device company, today proudly announced the successful conclusion of enrollment in their pilot study conducted in Australia for their minimally invasive, implantable migraine therapy.